|
AHCTF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.95918844983589E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.27530208615667E-11 |
| Normal-vs-Stage2 |
1.54159999999903E-05 |
| Normal-vs-Stage3 |
3.18020054734802E-10 |
| Normal-vs-Stage4 |
1.91699999996242E-06 |
| Stage1-vs-Stage2 |
6.250200E-01 |
| Stage1-vs-Stage3 |
3.971000E-01 |
| Stage1-vs-Stage4 |
8.348400E-01 |
| Stage2-vs-Stage3 |
3.220200E-01 |
| Stage2-vs-Stage4 |
8.289800E-01 |
| Stage3-vs-Stage4 |
4.546800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80055970133708E-12 |
| Normal-vs-AfricanAmerican |
4.659900E-02 |
| Normal-vs-Asian |
4.92889999925694E-08 |
| Caucasian-vs-AfricanAmerican |
1.321850E-02 |
| Caucasian-vs-Asian |
7.752000E-01 |
| AfricanAmerican-vs-Asian |
4.121600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05350003668059E-09 |
| Normal-vs-Female |
6.51001474949453E-12 |
| Male-vs-Female |
7.668400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.61069976537476E-10 |
| Normal-vs-Age(41-60Yrs) |
5.61970470158712E-11 |
| Normal-vs-Age(61-80Yrs) |
2.73589999544299E-08 |
| Normal-vs-Age(81-100Yrs) |
1.066060E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.819200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.550800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.364600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.338400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.647400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.920000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.204300E-03 |
| Classical-VS-Follicular |
1.215430E-01 |
| Classical-VS-Other |
2.673400E-01 |
| Classical-VS-Normal |
1.52250001494991E-09 |
| Tall-VS-Follicular |
1.618790E-01 |
| Tall-VS-Other |
9.494200E-01 |
| Tall-VS-Normal |
6.70150046566675E-10 |
| Follicular-VS-Other |
5.707000E-01 |
| Follicular-VS-Normal |
6.22910001357724E-09 |
| Other-VS-Normal |
2.322800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.71644945321259E-12 |
| Normal-vs-N1 |
1.21619999959854E-07 |
| N0-vs-N1 |
9.276600E-01 |
|
|
